Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.63 -0.02 (-3.58%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Interest Income - Net (2013 - 2016)

Updated

Biodexa Pharmaceuticals (BDRX) recorded Interest Income - Net of $283,480 in the year ended Dec 31, 2025, compared with -$4.12 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Interest Income - Net (2013 - 2016) Analysis & Trends

Starting with the year ended Dec 31, 2013, Biodexa Pharmaceuticals' Interest Income - Net history includes 13 years.

  • The figure for the year ended Dec 31, 2025 is the highest annual Interest Income - Net since the year ended Dec 31, 2018.
  • Per Business Quant data, BDRX's Interest Income - Net was -$4.12 million in the year ended Dec 31, 2024, $34,827 in the year ended Dec 31, 2023, -$434,401 in the year ended Dec 31, 2022 and -$1.07 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Net (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Biodexa Pharmaceuticals 41.69 Mn 18.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -1.57 Mn
Dec 31, 2015 -2.56 Mn
Dec 31, 2014 179,037.55
Dec 31, 2013 599,057.11
API Access

Biodexa Pharmaceuticals Interest Income - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-income-net&ticker=BDRX&period=max&api_key=YOUR_API_KEY